Sponsor:
Regeneron Pharmaceuticals
Code:
NCT07175428
Conditions
Atrial Fibrillation (AF)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
REGN7508
REGN9933
Apixaban
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-29. This information was provided to ClinicalTrials.gov by Regeneron Pharmaceuticals on 2026-03-18.